Kane Biotech senior management purchases 1.9 M shares
07 November 2018 | News
Biofilm is a very expensive problem in a wide variety of industries, there is no clear leader in the Biofilm space, and we're determined to take on that leadership position.
Kane Biotech Inc., has announced that Marc Edwards, Chief Executive Officer, and Ray Dupuis, Chief Financial Officer of Kane Biotech recently completed the purchases, from the open market, of a combined total of approximately 1.9 million shares of Kane Biotech's common stock.
Marc Edwards, Kane Biotech's Chief Executive Officer, stated, "I strongly believe in the future potential of our business, intellectual property and the world-class team we have assembled to take us there. I feel confident in investing in Kane Biotech as we begin solidifying commercial opportunities for the significant expansion and implementation of our anti-biofilm technologies. Biofilm is a very expensive problem in a wide variety of industries, there is no clear leader in the Biofilm space, and we're determined to take on that leadership position."
